Acquiring Company
Synchron
Acquired Company
ACQUANDAS
BrooklynKielerOtherBiotechnologyHealth CareMedical Equipment ManufacturingMedical Equipment ManufacturingDescription
Synchron, the brain-computer interface (BCI) company, has announced the acquisition of an equity stake in ACQUANDAS, a leading technology provider specializing in high-precision components for the healthcare industry. This acquisition strengthens Synchron's technology innovation and supply chain for their unique product offerings, particularly in the implantable medical device industry.
Other recent acquisitions in Medical Equipment Manufacturing and Medical Equipment Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- CardioFocus Acquires Electrophysiology Division of Galvanize Therapeutics (January 11, 2024)
- Novartis completes acquisition of IFM Due to develop first-in-class STING antagonist program targeting innate immune system (March 13, 2024)
- Branded Legacy, Inc. signs letter of intent to purchase Sycamore BioPharma, LLC, to strengthen its position in the BioTech industry (March 1, 2024)
- XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right (February 16, 2024)
- Novo Holdings to Acquire Catalent (February 5, 2024)
- Aditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap™ and NeuroEEG™ for Telehealth and Tele-neurology Applications (January 30, 2024)
Who to call at Synchron, and when
When Synchron changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Synchron raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Synchron, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Synchron. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Synchron makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired ACQUANDAS?
ACQUANDAS was acquired by Synchron, based in Brooklyn. The deal was reported on February 1, 2024. Synchron is developing implantable neurotechnology to unlock the brain and solve unmet medical needs at scale Synchron is privately held and operates in Other.
When did Synchron acquire ACQUANDAS?
Synchron's acquisition of ACQUANDAS was reported on February 1, 2024. Synchron, the brain-computer interface (BCI) company, has announced the acquisition of an equity stake in ACQUANDAS, a leading technology provider specializing in high-precision components for the healthcare industry. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does ACQUANDAS do?
Acquandas GmbH is a medical device OEM supplier founded in 2012 with its headquarter in Kiel, Germany. It is privately held, operating in Medical Equipment Manufacturing, and is based in Kieler.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.